JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

C5719 Oleyl Trifluoromethyl Ketone

Summary: potent inhibitor of FAAH

≤25 mg/mL
B1172 B-Raf inhibitor 1

Summary: Potent and selective B-Raf inhibitor

≥47.9 mg/mL
B1638 WYE-687

Summary: MTOR inhibitor,ATP-competitive and selective

insoluble in H2O; insoluble in EtOH; insoluble in DMSO
B1943 Fenofibrate
1 Citation

Summary: PPARα agonist

insoluble in H2O; ≥12.75 mg/mL
B1063 Tizanidine

Summary: α2 adrenergic agonist

insoluble in H2O; ≥11.45 mg/mL
B1134 Oxybutynin chloride

Summary: Anticholinergic medication

≥19.7 mg/mL
B1554 Benztropine mesylate

Summary: Dopamine transporter (DAT) inhibitor

≥20.18 mg/mL
B1438 BMS-794833

Target: MET|Flk-1

Summary: Met/VEGFR-2 inhibitor,potent and ATP-competitive

≥23.45 mg/mL
B1443 Bufexamac

Summary: COX inhibitor

insoluble in EtOH; ≥11.16 mg/mL
B1581 EPZ004777 HCl

Target: DOT1L

Summary: DOT1L inhibitor,potent and selective

insoluble in H2O; ≥16.5 mg/mL